Biden administration announces focus on ‘flooding the zone’ with life-saving overdose reversal medicine

The Biden administration launched an initiative Wednesday that it describes as a nationwide call to increase training on and access to life-saving opioid overdose reversal medications, dubbed the Challenge to Save Lives from Overdose.

The Biden administration launched an initiative Wednesday that it describes as a nationwide call to increase training on and access to life-saving opioid overdose reversal medications, dubbed the Challenge to Save Lives from Overdose. Naloxone, sometimes sold under the brand name Narcan, is a medication that can rapidly reverse the effects of an opioid overdose. Studies have showed that people are easily able to administer the life-saving drug in its nasal spray form without the need for any medical expertise and minimal training. To expand access, the US Food and Drug Administration approved an over-the-counter Narcan spray in March 2023, and it approved the first generic nonprescription nasal spray in July. Without the need for a prescription, anyone can buy the sprays at pharmacies, in grocery stores and even in vending machines. White House Domestic Policy Adviser Neera Tanden said in a briefing Tuesday that the overdose crisis is a “top priority” for the Biden administration, which has invested more than $100 billion to disrupt the flow of illicit drugs and expand access to drug treatment. Funding from the federal government’s State Opioid Response grant program has helped deliver nearly 10 million free naloxone kits across the country, preventing more than 600,000 overdose deaths, Tanden said, but the White House is now challenging private companies and people across all sectors to commit to increasing training and broadening access to the medication. Although naloxone is widely available, some public health officals say it is sometimes difficult to find, and the price can be prohibitive for some.